deferiprone has been researched along with Hyperoxia in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Hyperoxia: An abnormal increase in the amount of oxygen in the tissues and organs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soriano, S | 1 |
| Llorens, JV | 1 |
| Blanco-Sobero, L | 1 |
| Gutiérrez, L | 1 |
| Calap-Quintana, P | 1 |
| Morales, MP | 1 |
| Moltó, MD | 1 |
| Martínez-Sebastián, MJ | 1 |
1 other study available for deferiprone and Hyperoxia
| Article | Year |
|---|---|
Deferiprone and idebenone rescue frataxin depletion phenotypes in a Drosophila model of Friedreich's ataxia.
Topics: Aconitate Hydratase; Animals; Antioxidants; Deferiprone; Disease Models, Animal; Drosophila; Frataxi | 2013 |